Document Detail

Pharmacological approaches to methamphetamine dependence: a focused review.
MedLine Citation:
PMID:  20565449     Owner:  NLM     Status:  MEDLINE    
Methamphetamine dependence is a serious worldwide public health problem with major medical, psychiatric, socioeconomic and legal consequences. Various neuronal mechanisms implicated in methamphetamine dependence have suggested several pharmacological approaches. A literature search from a range of electronic databases (PubMed, EMBASE, PsycInfo, the NIDA research monograph index and the reference list of was conducted for the period from January 1985 to October 2009. There were no restrictions on the identification or inclusion of studies in terms of publication status, language and design type. A variety of medications have failed to show efficacy in clinical trials, including a dopamine partial agonist (aripiprazole), GABAergic agents (gabapentin) and serotonergic agents (SSRI, ondansetron, mirtazapine). Three double-blind placebo-controlled trials using modafinil, bupropion and naltrexone have shown positive results in reducing amphetamine or methamphetamine use. Two studies employing agonist replacement medications, one with d-amphetamine and the other with methylphenidate, have also shown promise. Despite the lack of success in most studies to date, increasing efforts are being made to develop medications for the treatment of methamphetamine dependence and several promising agents are targets of further research.
Laurent Karila; Aviv Weinstein; Henri-Jean Aubin; Amine Benyamina; Michel Reynaud; Steven L Batki
Related Documents :
18073269 - Development of medical checklists for improved quality of patient care.
19017859 - Penicillin and cephalosporin drug allergies: a paradigm shift.
7640829 - Heroin bodypacking.
12164069 - Subcritical solvothermal synthesis of condensed inorganic materials.
17272149 - A critical appraisal of opportunities for wearable medical sensors.
10303159 - Medline on cd-rom: end user searching in a medical school library.
18322569 - First-year residency candidates' experience in various areas of pharmacy practice.
2493599 - The medical care system and medical readiness training exercises (medretes) in honduras.
16740839 - Reported medication use in the neonatal intensive care unit: data from a large national...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  69     ISSN:  1365-2125     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-22     Completed Date:  2010-12-06     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  578-92     Citation Subset:  IM    
Addiction Research and Treatment Center, Paul Brousse Hospital, Paris XI University, AP-HP, CEA- INSERM U1000, Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amphetamine-Related Disorders / drug therapy*
Antipsychotic Agents / therapeutic use*
Calcium Channel Blockers / therapeutic use
Narcotic Antagonists / therapeutic use
Neurotransmitter Agents / therapeutic use*
Grant Support
5R01 DA016764-05/DA/NIDA NIH HHS; U10 DA015815/DA/NIDA NIH HHS
Reg. No./Substance:
0/Antipsychotic Agents; 0/Calcium Channel Blockers; 0/Narcotic Antagonists; 0/Neurotransmitter Agents; 537-46-2/Methamphetamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sapropterin.
Next Document:  Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.